Healthcare Industry News: IMRT
News Release - January 26, 2006
TomoTherapy Incorporated Continues Global ReachGermany to receive four Hi-Art Systems
MADISON, Wis.--(HSMN NewsFeed)--Jan. 26, 2006--The most advanced CT-guided radiation treatments are coming to Germany. TomoTherapy Incorporated announced today that The German Research Association (DFG) plans to install four TomoTherapy Hi-Art SystemsŪ in major universities throughout Germany later this year. The units have been chosen for Charite Berlin, the University Clinic Essen, the University Clinic Heidelberg, and the Clinic of the Technical University Munich Rechts der Isar. DFG anticipates the first sites may begin treating patients in the second half of 2006.
Jack Reese, TomoTherapy Director of European Sales, says it is unprecedented for a new technology to be adopted so quickly in this market. "History tells us that it is difficult to penetrate these major academic centers. In this case, history is not always an accurate predictor of future behavior. We have penetrated four key university sites in less than 10 months; a task that usually takes over 2 years. It is a sign of the significant change that TomoTherapy brings to this region and future patients."
The company's extraordinary sales success in Germany confirms that TomoTherapy is becoming a truly global company as it expands its reach for providing CT-Guided treatments to patients worldwide. Dr. Fred Robertson, TomoTherapy Chief Executive Officer, says this trend to permeate new markets will continue. "We have a market that is at least 50% outside of the United States. In the year ahead, I envision that half of our orders will come in Europe and Asia. We expect our growth to mirror growth opportunities in the global markets."
While TomoTherapy distribution systems continue to grow in the Asia/Pacific regions, Europe also remains a strong focus for the company. TomoTherapy currently maintains distribution systems in the United Kingdom, Benelux, France, Spain, Switzerland, Italy, Austria and Germany. Germany remains one of the largest markets and is an important indicator of continued growth and development that will no doubt continue in this region.
About TomoTherapy Incorporated
Based in Madison, Wisconsin, TomoTherapy Incorporated (www.tomotherapy.com) has developed a revolutionary new medical system that combines on-board CT imaging with conformal radiation therapy to provide unprecedented precision in the treatment of cancer patients. TomoTherapy leads the industry with the most advanced IG/IMRT treatments. The TomoTherapy Hi-Art SystemŪ is designed to target radiation treatment to the patient's tumor while helping to limit damage to the surrounding tissues. The TomoTherapy technology was created from a collaboration with the University of Wisconsin. To find out more, please visit our website at www.tomotherapy.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.